{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:11:39Z","timestamp":1792141899424,"version":"4.4.0"},"reference-count":188,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000910","name":"Conrad N. Hilton Foundation","doi-asserted-by":"publisher","award":["17313"],"award-info":[{"award-number":["17313"]}],"id":[{"id":"10.13039\/100000910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Cariplo Foundation","doi-asserted-by":"publisher","award":["2019\u20131677"],"award-info":[{"award-number":["2019\u20131677"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Regionale per la Ricerca Biomedica Early Career Award","award":["1750327"],"award-info":[{"award-number":["1750327"]}]},{"name":"NMSS Society","award":["RFA-2203-39325"],"award-info":[{"award-number":["RFA-2203-39325"]}]},{"DOI":"10.13039\/100017147","name":"International Progressive MS Alliance","doi-asserted-by":"publisher","award":["PA-2107-38081"],"award-info":[{"award-number":["PA-2107-38081"]}],"id":[{"id":"10.13039\/100017147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["RG-1802-30140"],"award-info":[{"award-number":["RG-1802-30140"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["JF-2008-36971"],"award-info":[{"award-number":["JF-2008-36971"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["AWD-00005884"],"award-info":[{"award-number":["AWD-00005884"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["PP-1809-32498"],"award-info":[{"award-number":["PP-1809-32498"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS116776-01"],"award-info":[{"award-number":["U01NS116776-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RG-1901-33190"],"award-info":[{"award-number":["RG-1901-33190"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS116434-01A1"],"award-info":[{"award-number":["R21 NS116434-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Health Administration","award":["I01CX002160-01A1"],"award-info":[{"award-number":["I01CX002160-01A1"]}]},{"name":"Voros Innovation Impact Funds","award":["R01NS082347"],"award-info":[{"award-number":["R01NS082347"]}]},{"DOI":"10.13039\/100020324","name":"Principia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012159","name":"Myelin Repair Foundation","doi-asserted-by":"publisher","award":["R01 NS104283"],"award-info":[{"award-number":["R01 NS104283"]}],"id":[{"id":"10.13039\/100012159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012159","name":"Myelin Repair Foundation","doi-asserted-by":"publisher","award":["R01 105144"],"award-info":[{"award-number":["R01 105144"]}],"id":[{"id":"10.13039\/100012159","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH-NINDS","award":["1R01NS122980-01"],"award-info":[{"award-number":["1R01NS122980-01"]}]},{"name":"NIH-NINDS","award":["1R01NS104403-01"],"award-info":[{"award-number":["1R01NS104403-01"]}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["MS210103"],"award-info":[{"award-number":["MS210103"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["RG-2110-38460"],"award-info":[{"award-number":["RG-2110-38460"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["K23NS126718"],"award-info":[{"award-number":["K23NS126718"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001454"],"award-info":[{"award-number":["KL2TR001454"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016253","name":"Atara","doi-asserted-by":"publisher","award":["RG-1707-28775"],"award-info":[{"award-number":["RG-1707-28775"]}],"id":[{"id":"10.13039\/100016253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016253","name":"Atara","doi-asserted-by":"publisher","award":["W81XWH-14-1-0493"],"award-info":[{"award-number":["W81XWH-14-1-0493"]}],"id":[{"id":"10.13039\/100016253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005191","name":"Craig H. Neilsen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021409","name":"International Collaboration on Repair Discoveries","doi-asserted-by":"publisher","award":["1R21NS1226737-01"],"award-info":[{"award-number":["1R21NS1226737-01"]}],"id":[{"id":"10.13039\/501100021409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021409","name":"International Collaboration on Repair Discoveries","doi-asserted-by":"publisher","award":["1R21NS123419-01"],"award-info":[{"award-number":["1R21NS123419-01"]}],"id":[{"id":"10.13039\/501100021409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021409","name":"International Collaboration on Repair Discoveries","doi-asserted-by":"publisher","award":["R01DA047088-01"],"award-info":[{"award-number":["R01DA047088-01"]}],"id":[{"id":"10.13039\/501100021409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021409","name":"International Collaboration on Repair Discoveries","doi-asserted-by":"publisher","award":["RG-1802-30468"],"award-info":[{"award-number":["RG-1802-30468"]}],"id":[{"id":"10.13039\/501100021409","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roche-Genentech"},{"DOI":"10.13039\/501100000261","name":"MS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"publisher","award":["1U01NS116776-01"],"award-info":[{"award-number":["1U01NS116776-01"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"publisher","award":["U01 NS116776-01"],"award-info":[{"award-number":["U01 NS116776-01"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"publisher","award":["R35 NS097303"],"award-info":[{"award-number":["R35 NS097303"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"publisher","award":["R56 NR019306-01A1"],"award-info":[{"award-number":["R56 NR019306-01A1"]}],"id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["MS-1610-37047"],"award-info":[{"award-number":["MS-1610-37047"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["W81XWH2110787"],"award-info":[{"award-number":["W81XWH2110787"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["RG-1902-33619"],"award-info":[{"award-number":["RG-1902-33619"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["R01 NS102267"],"award-info":[{"award-number":["R01 NS102267"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["R01 NS112907"],"award-info":[{"award-number":["R01 NS112907"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["R01 NS118886"],"award-info":[{"award-number":["R01 NS118886"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["R21 NS129197"],"award-info":[{"award-number":["R21 NS129197"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["W81XWH2010580"],"award-info":[{"award-number":["W81XWH2010580"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["SI-2004-36589"],"award-info":[{"award-number":["SI-2004-36589"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intramural Research Program of NIH-NINDS","award":["Z01 NS003119"],"award-info":[{"award-number":["Z01 NS003119"]}]},{"name":"Intramural Research Program of NIH-NINDS","award":["R01 NS40801"],"award-info":[{"award-number":["R01 NS40801"]}]},{"name":"Intramural Research Program of NIH-NINDS","award":["R01-EB007258"],"award-info":[{"award-number":["R01-EB007258"]}]},{"name":"Intramural Research Program of NIH-NINDS","award":["RG-2110-38526"],"award-info":[{"award-number":["RG-2110-38526"]}]},{"name":"Intramural Research Program of NIH-NINDS","award":["U01 NS116776-01"],"award-info":[{"award-number":["U01 NS116776-01"]}]},{"name":"Erwin Rautenberg Foundation","award":["R01 NS 112274"],"award-info":[{"award-number":["R01 NS 112274"]}]},{"name":"Erwin Rautenberg Foundation","award":["R01 MH 123550"],"award-info":[{"award-number":["R01 MH 123550"]}]},{"name":"Erwin Rautenberg Foundation","award":["R01 MH 112847"],"award-info":[{"award-number":["R01 MH 112847"]}]},{"name":"Erwin Rautenberg Foundation","award":["R01 NS060910"],"award-info":[{"award-number":["R01 NS060910"]}]},{"name":"Erwin Rautenberg Foundation","award":["U01 NS116776"],"award-info":[{"award-number":["U01 NS116776"]}]},{"name":"Erwin Rautenberg Foundation","award":["U01 NS116776-01"],"award-info":[{"award-number":["U01 NS116776-01"]}]},{"name":"Erwin Rautenberg Foundation","award":["MS-1610-37115"],"award-info":[{"award-number":["MS-1610-37115"]}]},{"name":"Erwin Rautenberg Foundation","award":["R35NS097303"],"award-info":[{"award-number":["R35NS097303"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chronic active lesions (CAL) are an important manifestation of chronic inflammation in multiple sclerosis and have implications for non-relapsing biological progression. In recent years, the discovery of innovative MRI and PET-derived biomarkers has made it possible to detect CAL, and to some extent quantify them, in the brain of persons with multiple sclerosis, in vivo.<\/jats:p>\n               <jats:p>Paramagnetic rim lesions on susceptibility-sensitive MRI sequences, MRI-defined slowly expanding lesions on T1-weighted and T2-weighted scans, and 18-kDa translocator protein-positive lesions on PET are promising candidate biomarkers of CAL. While partially overlapping, these biomarkers do not have equivalent sensitivity and specificity to histopathological CAL. Standardization in the use of available imaging measures for CAL identification, quantification and monitoring is lacking.<\/jats:p>\n               <jats:p>To fast-forward clinical translation of CAL, the North American Imaging in Multiple Sclerosis Cooperative developed a consensus statement, which provides guidance for the radiological definition and measurement of CAL. The proposed manuscript presents this consensus statement, summarizes the multistep process leading to it, and identifies the remaining major gaps in knowledge.<\/jats:p>","DOI":"10.1093\/brain\/awae013","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T12:27:47Z","timestamp":1705408067000},"page":"2913-2933","source":"Crossref","is-referenced-by-count":203,"title":["Imaging chronic active lesions in multiple sclerosis: a consensus statement"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9544-9019","authenticated-orcid":false,"given":"Francesca","family":"Bagnato","sequence":"first","affiliation":[{"name":"Neuroimaging Unit, Neuroimmunology Division, Department of Neurology, Vanderbilt University Medical Center , Nashville, TN 37212 ,","place":["USA"]},{"name":"Department of Neurology, Nashville VA Medical Center, Tennessee Valley Healthcare System , Nashville, TN 37212 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sati","sequence":"additional","affiliation":[{"name":"Neuroimaging Program, Department of Neurology, Cedars-Sinai Medical Center , Los Angeles, CA 90048 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Hemond","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Massachusetts Chan Medical School , Worcester, MA 01655 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-523X","authenticated-orcid":false,"given":"Colm","family":"Elliott","sequence":"additional","affiliation":[{"name":"NeuroRx Research , Montr\u00e9al, QC H2X 3P9 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-1781","authenticated-orcid":false,"given":"Susan A","family":"Gauthier","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Cornell Medicine , New York, NY 10021 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Maryland School of Medicine , Baltimore, MD 21201 ,","place":["USA"]},{"name":"Department of Neurology, Baltimore VA Medical Center, VA Maryland Healthcare System , Baltimore, MD 21201 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mainero","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Oh","sequence":"additional","affiliation":[{"name":"Division of Neurology, St. Michael\u2019s Hospital, University of Toronto , Toronto, ON M5S ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pitt","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine , New Haven, CT 06510 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell T","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Penn Statistics in Imaging and Visualization Endeavor, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Center for Biomedical Image Computing and Analytics, Department of Radiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiological Sciences, Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center , Nashville, TN 37235 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Trapp","sequence":"additional","affiliation":[{"name":"Department on Neurosciences, Lerner Research Institute, Cleveland Clinic , Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J","family":"Azevedo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keck School of Medicine of the University of Southern California , Los Angeles, CA 90007 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6472","authenticated-orcid":false,"given":"Peter A","family":"Calabresi","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine , Baltimore, MD 21205 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland G","family":"Henry","sequence":"additional","affiliation":[{"name":"Weill Institute for Neurosciences, Department of Neurology, University of California , San Francisco, CA 94158 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Laule","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of British Columbia , Vancouver, BC V6T 1Z4 ,","place":["Canada"]},{"name":"Department of Pathology & Laboratory Medicine, University of British Columbia , Vancouver, BC V6T 1Z4 ,","place":["Canada"]},{"name":"Department of Physics and Astronomy, University of British Columbia , Vancouver, BC V6T 1Z4 ,","place":["Canada"]},{"name":"International Collaboration on Repair Discoveries (ICORD), University of British Columbia , Vancouver, BC V6T 1Z4 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-9148","authenticated-orcid":false,"given":"Daniel","family":"Ontaneda","sequence":"additional","affiliation":[{"name":"Mellen Center for Multiple Sclerosis, Cleveland Clinic , Cleveland, OH 44195 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Rooney","sequence":"additional","affiliation":[{"name":"Advanced Imaging Research Center, Oregon Health and Science University , Portland, OR 97239 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L","family":"Sicotte","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cedars-Sinai Medical Center , Los Angeles, CA 90048 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-4334","authenticated-orcid":false,"given":"Daniel S","family":"Reich","sequence":"additional","affiliation":[{"name":"Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-383X","authenticated-orcid":false,"given":"Martina","family":"Absinta","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine , Baltimore, MD 21205 ,","place":["USA"]},{"name":"Translational Neuropathology Unit, Division of Neuroscience, Institute of Experimental Neurology, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute , Milan, 20132 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"2025011602331786800_awae013-B1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ana.410340507","article-title":"Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis","volume":"34","author":"Katz","year":"1993","journal-title":"Ann Neurol"},{"issue":"S1","key":"2025011602331786800_awae013-B2","first-page":"S26","article-title":"The lesion in multiple sclerosis: Clinical, pathological, and magnetic resonance imaging considerations","volume":"64","author":"McFarland","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025011602331786800_awae013-B3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.410290515","article-title":"Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history","volume":"29","author":"Harris","year":"1991","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.45.6.1122","article-title":"Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender, and age","volume":"45","author":"Stone","year":"1995","journal-title":"Neurology"},{"key":"2025011602331786800_awae013-B5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410330511","article-title":"Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions","volume":"33","author":"Smith","year":"1993","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.1255","article-title":"Immunopathology of secondary-progressive multiple sclerosis","volume":"50","author":"Prineas","year":"2001","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.410050105","article-title":"Remyelination in multiple sclerosis","volume":"5","author":"Prineas","year":"1979","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneurol.2010.148","article-title":"Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging","volume":"67","author":"Pitt","year":"2010","journal-title":"Arch Neurol"},{"key":"2025011602331786800_awae013-B9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1352458508096876","article-title":"Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging","volume":"15","author":"Gilmore","year":"2009","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-024-02700-6","article-title":"The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study","volume":"147","author":"Waldman","year":"2024","journal-title":"Acta Neuropathol."},{"key":"2025011602331786800_awae013-B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2025011602331786800_awae013-B12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/brain\/awy082","article-title":"Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination","volume":"141","author":"Lee","year":"2018","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: A retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2025011602331786800_awae013-B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00401-017-1696-8","article-title":"Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions","volume":"134","author":"Popescu","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2025011602331786800_awae013-B16","doi-asserted-by":"crossref","first-page":"e200025","DOI":"10.1212\/NXI.0000000000200025","article-title":"Toward precision phenotyping of multiple sclerosis","volume":"9","author":"Pitt","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: Time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"2025011602331786800_awae013-B18","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1177\/1352458517739990","article-title":"The NAIMS cooperative pilot project: Design, implementation, and future directions","volume":"24","author":"Oh","year":"2017","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B19"},{"key":"2025011602331786800_awae013-B20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"J\u00e4kel","year":"2019","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","article-title":"MAFG-driven astrocytes promote CNS inflammation","volume":"578","author":"Wheeler","year":"2020","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/jcbfm.2013.85","article-title":"Adenosine A2A receptors in secondary progressive multiple sclerosis: A [11C]TMSX brain PET study","volume":"33","author":"Rissanen","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025011602331786800_awae013-B27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFN\u03b3+ NK cells drive LAMP1 + TRAIL+ anti-inflammatory astrocytes","volume":"590","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"2025011602331786800_awae013-B28","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","article-title":"Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease","volume":"11","author":"Olah","year":"2020","journal-title":"Nat Commun"},{"key":"2025011602331786800_awae013-B29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"2025011602331786800_awae013-B30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B32","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"2025011602331786800_awae013-B33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1468-1331.1999.640455.x","article-title":"Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis","volume":"6","author":"Ciccarelli","year":"1999","journal-title":"Eur J Neurol"},{"key":"2025011602331786800_awae013-B35","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/brain\/awg182","article-title":"Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years","volume":"126","author":"Bagnato","year":"2003","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B36"},{"key":"2025011602331786800_awae013-B37","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/brain\/awr278","article-title":"Tracking iron in multiple sclerosis: A combined imaging and histopathological study at 7 Tesla","volume":"134","author":"Bagnato","year":"2011","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1148\/radiol.11110601","article-title":"Chronic multiple sclerosis lesions: Characterization with high-field-strength MR imaging","volume":"262","author":"Yao","year":"2012","journal-title":"Radiology"},{"key":"2025011602331786800_awae013-B39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.12120863","article-title":"Multiple sclerosis: Validation of MR imaging for quantification and detection of iron","volume":"267","author":"Walsh","year":"2013","journal-title":"Radiology"},{"key":"2025011602331786800_awae013-B40","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/tomography8030127","article-title":"Magnetic susceptibility source separation solely from gradient echo data: Histological validation","volume":"8","author":"Dimov","year":"2022","journal-title":"Tomography"},{"key":"2025011602331786800_awae013-B41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/awy296","article-title":"Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions","volume":"142","author":"Kaunzner","year":"2019","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.51338","article-title":"QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions","volume":"8","author":"Gillen","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2025011602331786800_awae013-B43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.26441","article-title":"A new advanced MRI biomarker for remyelinated lesions in multiple sclerosis","volume":"92","author":"Rahmanzadeh","year":"2022","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B44","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-Tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J Clin Invest"},{"key":"2025011602331786800_awae013-B45","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol"},{"key":"2025011602331786800_awae013-B46","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1212\/WNL.0000000000012326","article-title":"Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis","volume":"97","author":"Maggi","year":"2021","journal-title":"Neurology"},{"key":"2025011602331786800_awae013-B47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ana.26194","article-title":"7T MRI differentiates remyelinated from demyelinated multiple sclerosis lesions","volume":"90","author":"Kolb","year":"2021","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.23959","article-title":"Seven-tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory process","volume":"74","author":"Absinta","year":"2013","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: Pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2025011602331786800_awae013-B50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/brain\/awaa436","article-title":"Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI","volume":"144","author":"Dal-Bianco","year":"2021","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B51","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jon.12193","article-title":"Heterogeneity of multiple sclerosis white matter lesions detected with T2*-weighted imaging at 7.0 tesla","volume":"25","author":"Yao","year":"2015","journal-title":"J Neuroimaging"},{"key":"2025011602331786800_awae013-B52","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3174\/ajnr.A4729","article-title":"Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI","volume":"37","author":"Chawla","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3174\/ajnr.A4726","article-title":"Lesion heterogeneity on high-field susceptibility MRI is associated with multiple sclerosis severity","volume":"37","author":"Harrison","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1148\/radiol.13130353","article-title":"Quantitative susceptibility mapping of multiple sclerosis lesions at various ages","volume":"271","author":"Chen","year":"2014","journal-title":"Radiology"},{"key":"2025011602331786800_awae013-B55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1148\/rg.254055027","article-title":"Fundamental physics of MR imaging","volume":"25","author":"Pooley","year":"2005","journal-title":"RadioGraphics"},{"key":"2025011602331786800_awae013-B56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mrm.25420","article-title":"Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron","volume":"74","author":"Wisnieff","year":"2014","journal-title":"Magn Reson Med"},{"key":"2025011602331786800_awae013-B57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00062-015-0389-8","article-title":"Chronic T2 lesions in multiple sclerosis are heterogeneous regarding phase MR imaging","volume":"26","author":"Siemonsen","year":"2016","journal-title":"Clin Neuroradiol"},{"key":"2025011602331786800_awae013-B58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3988\/jcn.2020.16.4.562","article-title":"Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: A quantitative susceptibility mapping study with 3-T MRI","volume":"16","author":"Jang","year":"2020","journal-title":"J Clin Neurol"},{"key":"2025011602331786800_awae013-B59","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3174\/ajnr.A6547","article-title":"Value of 3T susceptibility-weighted imaging in the diagnosis of multiple sclerosis","volume":"41","author":"Clarke","year":"2020","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B60","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1007\/s00330-020-06995-3","article-title":"Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions","volume":"30","author":"Caruana","year":"2020","journal-title":"Eur Radiol"},{"key":"2025011602331786800_awae013-B61","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s00330-021-08233-w","article-title":"Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis","volume":"32","author":"Weber","year":"2022","journal-title":"Eur Radiol"},{"key":"2025011602331786800_awae013-B62","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458514525868","article-title":"Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis","volume":"20","author":"Sati","year":"2014","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B63","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3174\/ajnr.A5660","article-title":"Identification of chronic active multiple sclerosis lesions on 3T MRI","volume":"39","author":"Absinta","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: An international multicenter 3T MRI study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B65","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00234-021-02768-x","article-title":"Rim lesions are demonstrated in early relapsing-remitting multiple sclerosis using 3T-based susceptibility-weighted imaging in a multi-institutional setting","volume":"64","author":"Ng Kee Kwong","year":"2022","journal-title":"Neuroradiology"},{"key":"2025011602331786800_awae013-B66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00234-021-02800-0","article-title":"Smoldering lesions in MS: If you like it then you should put a rim on it","volume":"64","author":"Pinto","year":"2022","journal-title":"Neuroradiology"},{"key":"2025011602331786800_awae013-B67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1148\/radiol.2021203071","article-title":"Susceptibility-weighted imaging: Technical essentials and clinical neurologic applications","volume":"299","author":"Haller","year":"2021","journal-title":"Radiology"},{"key":"2025011602331786800_awae013-B68","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1364\/OL.28.001194","article-title":"Fast phase unwrapping algorithm for interferometric applications","volume":"28","author":"Schofield","year":"2003","journal-title":"Opt Lett"},{"key":"2025011602331786800_awae013-B69","doi-asserted-by":"crossref","first-page":"134058","DOI":"10.1155\/2014\/134058","article-title":"Sparse-representation-based direct minimum L (p) -norm algorithm for MRI phase unwrapping","volume":"2014","author":"He","year":"2014","journal-title":"Comput Math Methods Med"},{"key":"2025011602331786800_awae013-B70","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jmri.24501","article-title":"Quantitative assessment of susceptibility weighted imaging processing methods","volume":"40","author":"Li","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"2025011602331786800_awae013-B71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/nbm.3056","article-title":"Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping","volume":"27","author":"Li","year":"2014","journal-title":"NMR Biomed"},{"key":"2025011602331786800_awae013-B72","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.neuroimage.2010.10.070","article-title":"Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism?","volume":"54","author":"Schweser","year":"2011","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mrm.24765","article-title":"Background field removal using spherical mean value filtering and Tikhonov regularization","volume":"71","author":"Sun","year":"2014","journal-title":"Magn Reson Med"},{"key":"2025011602331786800_awae013-B74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmri.24745","article-title":"Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging","volume":"42","author":"Eskreis-Winkler","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"2025011602331786800_awae013-B75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10334-016-0560-5","article-title":"A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field","volume":"29","author":"Cronin","year":"2016","journal-title":"MAGMA"},{"key":"2025011602331786800_awae013-B76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jmri.24768","article-title":"Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain","volume":"42","author":"Liu","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"2025011602331786800_awae013-B77","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/mrm.22334","article-title":"Susceptibility mapping in the human brain using threshold-based k-space division","volume":"63","author":"Wharton","year":"2010","journal-title":"Magn Reson Med"},{"key":"2025011602331786800_awae013-B78","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.neuroimage.2011.08.082","article-title":"Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map","volume":"59","author":"Liu","year":"2012","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B79","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.neuroimage.2012.05.067","article-title":"Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain","volume":"62","author":"Schweser","year":"2012","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B80","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/nbm.3383","article-title":"Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range","volume":"28","author":"Wei","year":"2015","journal-title":"NMR Biomed"},{"key":"2025011602331786800_awae013-B81","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neuroimage.2015.02.041","article-title":"Fast quantitative susceptibility mapping using 3D EPI and total generalized variation","volume":"111","author":"Langkammer","year":"2015","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B82","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1109\/TMI.2016.2544958","article-title":"Quantitative susceptibility mapping using structural feature based collaborative reconstruction (SFCR) in the human brain","volume":"35","author":"Bao","year":"2016","journal-title":"IEEE Trans Med Imaging"},{"key":"2025011602331786800_awae013-B83","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/mrm.26946","article-title":"MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping","volume":"79","author":"Liu","year":"2017","journal-title":"Magn Reson Med"},{"key":"2025011602331786800_awae013-B84","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.neuroimage.2010.03.045","article-title":"In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique","volume":"51","author":"Sati","year":"2010","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B85","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuroimage.2012.01.108","article-title":"Gradient echo plural contrast imaging-signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI","volume":"60","author":"Luo","year":"2012","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B86","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2214\/AJR.21.26777","article-title":"Paramagnetic rim lesions in multiple sclerosis: Comparison of visualization at 1.5-T and 3-T MRI","volume":"219","author":"Hemond","year":"2022","journal-title":"Am J Roentgenol"},{"key":"2025011602331786800_awae013-B87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/jon.12987","article-title":"Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination","volume":"32","author":"Huang","year":"2022","journal-title":"J Neuroimaging"},{"key":"2025011602331786800_awae013-B88","doi-asserted-by":"crossref","first-page":"102412","DOI":"10.1016\/j.nicl.2020.102412","article-title":"RimNet: A deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis","volume":"28","author":"Barquero","year":"2020","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B89","doi-asserted-by":"crossref","first-page":"102796","DOI":"10.1016\/j.nicl.2021.102796","article-title":"Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging","volume":"32","author":"Lou","year":"2021","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B90","doi-asserted-by":"crossref","first-page":"102335","DOI":"10.1016\/j.nicl.2020.102335","article-title":"Multiple sclerosis cortical and white matter lesion segmentation at 3T MRI: A deep learning method based on FLAIR and MP2RAGE","volume":"27","author":"La Rosa","year":"2020","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jon.12506","article-title":"MIMoSA: An automated method for intermodal segmentation analysis of multiple sclerosis brain lesions","volume":"28","author":"Valcarcel","year":"2018","journal-title":"J Neuroimaging"},{"key":"2025011602331786800_awae013-B92","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.nicl.2018.10.013","article-title":"A dual modeling approach to automatic segmentation of cerebral T2 hyperintensities and T1 black holes in multiple sclerosis","volume":"20","author":"Valcarcel","year":"2018","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B93","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3174\/ajnr.A5556","article-title":"An automated statistical technique for counting distinct multiple sclerosis lesions","volume":"39","author":"Dworkin","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B94","doi-asserted-by":"crossref","first-page":"e006843","DOI":"10.1161\/CIRCIMAGING.117.006843","article-title":"Radiomic features are superior to conventional quantitative computed tomographic metrics to identify coronary plaques with napkin-ring sign","volume":"10","author":"Kolossv\u00e1ry","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025011602331786800_awae013-B95","doi-asserted-by":"crossref","first-page":"102979","DOI":"10.1016\/j.nicl.2022.102979","article-title":"QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps","volume":"34","author":"Zhang","year":"2022","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B96","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s00415-022-11082-2","article-title":"MRI predictors for the conversion from contrast enhancing to iron rim multiple sclerosis lesions","volume":"269","author":"Wenzel","year":"2022","journal-title":"J Neurol"},{"key":"2025011602331786800_awae013-B97","first-page":"987","article-title":"Quantitative susceptibility mapping of time-dependent susceptibility changes in multiple sclerosis lesions","volume":"40","author":"Zhang","year":"2019","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B98","doi-asserted-by":"crossref","first-page":"103340","DOI":"10.1016\/j.msard.2021.103340","article-title":"Long-term dynamics of multiple sclerosis iron rim lesions","volume":"57","author":"Weber","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2025011602331786800_awae013-B99","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ana.26727","article-title":"Early magnetic resonance imaging features of new paramagnetic rim lesions in multiple sclerosis","volume":"94","author":"Clark","year":"2023","journal-title":"Ann Neurol"},{"issue":"3","key":"2025011602331786800_awae013-B100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jmri.28847","article-title":"Evaluation of the blood-brain barrier, demyelination, and neurodegeneration in paramagnetic rim lesions in multiple sclerosis on 7 Tesla MRI","volume":"59","author":"Choi","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"2025011602331786800_awae013-B101","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00234-021-02768-x","article-title":"Rim lesions are demonstrated in early relapsing-remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional setting","volume":"64","author":"Ng Kee Kwong","year":"2022","journal-title":"Neuroradiology"},{"key":"2025011602331786800_awae013-B102","doi-asserted-by":"crossref","first-page":"fcab134","DOI":"10.1093\/braincomms\/fcab134","article-title":"Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression","volume":"3","author":"Treaba","year":"2021","journal-title":"Brain Commun"},{"key":"2025011602331786800_awae013-B103","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1177\/13524585221102921","article-title":"Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study","volume":"28","author":"Hemond","year":"2022","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B104","article-title":"Evaluation of the \u201cring sign\u201d and the \u201ccore sign\u201d as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis","volume":"6","author":"Blindenbacher","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"2025011602331786800_awae013-B105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1177\/13524585231197954","article-title":"Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis","volume":"29","author":"Krajnc","year":"2023","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3174\/ajnr.A5482","article-title":"Combining quantitative susceptibility mapping with automatic zero reference (QSM0) and myelin water fraction imaging to quantify IronRelated myelin damage in chronic active MS lesions","volume":"39","author":"Yao","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B107","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/brain\/awab088","article-title":"Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging","volume":"144","author":"Rahmanzadeh","year":"2021","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jmri.23603","article-title":"Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: A case control study","volume":"36","author":"Hagemeier","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"2025011602331786800_awae013-B109","first-page":"1473","article-title":"Morphology-Specific discrimination between MS white matter lesions and benign white matter hyperintensities using ultra-HighField MRI","volume":"39","author":"Hosseini","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B110","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1212\/NXI.0000000000000259","article-title":"MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T","volume":"3","author":"Sinnecker","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B111","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1177\/1352458512441270","article-title":"Lesion morphology at 7 tesla MRI differentiates Susac syndrome from multiple sclerosis","volume":"18","author":"Wuerfel","year":"2012","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B112","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1177\/13524585221118677","article-title":"Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis","volume":"28","author":"Meaton","year":"2022","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B113","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00330-013-3080-y","article-title":"Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla","volume":"24","author":"Kilsdonk","year":"2014","journal-title":"Eur Radiol"},{"key":"2025011602331786800_awae013-B114","doi-asserted-by":"crossref","first-page":"e220941","DOI":"10.1148\/radiol.220941","article-title":"\u03c7-Separation imaging for diagnosis of multiple sclerosis versus neuromyelitis optica spectrum disorder","volume":"307","author":"Kim","year":"2023","journal-title":"Radiology"},{"key":"2025011602331786800_awae013-B115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jamaneurol.2020.0124","article-title":"Paramagnetic rim sign in radiologically isolated syndrome","volume":"77","author":"Suthiphosuwan","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025011602331786800_awae013-B116","doi-asserted-by":"crossref","first-page":"103183","DOI":"10.1016\/j.msard.2021.103183","article-title":"Radiologically isolated syndrome: A singlecenter, retrospective cohort study","volume":"55","author":"George","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"2025011602331786800_awae013-B117","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1038\/s41598-022-08477-6","article-title":"Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis","volume":"12","author":"Marcille","year":"2022","journal-title":"Sci Rep"},{"key":"2025011602331786800_awae013-B118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/13524585211010082","article-title":"CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event","volume":"28","author":"Comabella","year":"2021","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B119","doi-asserted-by":"crossref","first-page":"647519","DOI":"10.3389\/fneur.2021.647519","article-title":"The distributional characteristics of multiple sclerosis lesions on quantitative susceptibility mapping and their correlation with clinical severity","volume":"12","author":"Guo","year":"2021","journal-title":"Front Neurol"},{"key":"2025011602331786800_awae013-B120","doi-asserted-by":"crossref","first-page":"e2353","DOI":"10.1002\/brb3.2353","article-title":"Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis","volume":"11","author":"Tozlu","year":"2021","journal-title":"Brain Behav"},{"key":"2025011602331786800_awae013-B121","doi-asserted-by":"crossref","first-page":"103967","DOI":"10.1016\/j.msard.2022.103967","article-title":"Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability","volume":"64","author":"Wittayer","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2025011602331786800_awae013-B122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mri.2022.10.009","article-title":"Exploring (peri-) lesional and structural connectivity tissue damage through T1\/T2-weighted ratio in iron rim multiple sclerosis lesions","volume":"95","author":"Wittayer","year":"2023","journal-title":"Magn Reson Imaging"},{"issue":"4\u20135","key":"2025011602331786800_awae013-B123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/13524585231155639","article-title":"Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesions","volume":"29","author":"Wittayer","year":"2023","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B124","doi-asserted-by":"crossref","first-page":"632749","DOI":"10.3389\/fneur.2021.632749","article-title":"Iron rims in patients with multiple sclerosis as neurodegenerative marker? A 7-tesla magnetic resonance study","volume":"12","author":"Dal-Bianco","year":"2021","journal-title":"Front Neurol"},{"key":"2025011602331786800_awae013-B125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.12688\/wellcomeopenres.9967.2","article-title":"Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis","volume":"1","author":"Lewin","year":"2016","journal-title":"Wellcome Open Res"},{"key":"2025011602331786800_awae013-B126","doi-asserted-by":"crossref","first-page":"928582","DOI":"10.3389\/fneur.2022.928582","article-title":"Peripheral hemolysis in relation to iron rim presence and brain volume in multiple sclerosis","volume":"13","author":"Krajnc","year":"2022","journal-title":"Front Neurol"},{"key":"2025011602331786800_awae013-B127","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1177\/13524585221114750","article-title":"Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis","volume":"28","author":"Altokhis","year":"2022","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/13524585221141964","article-title":"Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Calvi","year":"2023","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B129","doi-asserted-by":"crossref","first-page":"104701","DOI":"10.1016\/j.ebiom.2023.104701","article-title":"B cell depletion therapy does not resolve chronic active multiple sclerosis lesions","volume":"94","author":"Maggi","year":"2023","journal-title":"EBioMedicine"},{"key":"2025011602331786800_awae013-B130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/WNL.0b013e3181b64bf7","article-title":"In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI","volume":"73","author":"Mainero","year":"2009","journal-title":"Neurology"},{"key":"2025011602331786800_awae013-B131","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3174\/ajnr.A5150","article-title":"Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis","volume":"38","author":"Castellaro","year":"2017","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B132","doi-asserted-by":"crossref","first-page":"118371","DOI":"10.1016\/j.neuroimage.2021.118371","article-title":"\u03c7-separation: Magnetic susceptibility source separation toward iron and myelin mapping in the brain","volume":"240","author":"Shin","year":"2021","journal-title":"Neuroimage"},{"key":"2025011602331786800_awae013-B133","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.0b013e3182635645","article-title":"Increased PK11195 PET binding in the cortex of patients with MS correlates with disability","volume":"79","author":"Politis","year":"2012","journal-title":"Neurology"},{"key":"2025011602331786800_awae013-B134","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ana.24791","article-title":"Neuroinflammatory component of gray matter pathology in multiple sclerosis","volume":"80","author":"Herranz","year":"2016","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B135","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1212\/NXI.0000000000000587","article-title":"Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study","volume":"6","author":"Singhal","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B136","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/1352458519867320","article-title":"Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging","volume":"26","author":"Herranz","year":"2019","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B137","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B138","doi-asserted-by":"crossref","first-page":"103048","DOI":"10.1016\/j.nicl.2022.103048","article-title":"Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis","volume":"35","author":"Calvi","year":"2022","journal-title":"Neuroimage Clin"},{"key":"2025011602331786800_awae013-B139","first-page":"1584","article-title":"Patterning chronic active demyelination in slowly expanding\/evolving white matter MS lesions","volume":"41","author":"Elliott","year":"2020","journal-title":"Am J Neuroradiol"},{"key":"2025011602331786800_awae013-B140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1191\/1352458505ms1229oa","article-title":"Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis","volume":"11","author":"Gupta","year":"2005","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B141"},{"key":"2025011602331786800_awae013-B142","doi-asserted-by":"crossref","first-page":"e000240","DOI":"10.1136\/bmjno-2021-000240","article-title":"Chronic lesion activity and disability progression in secondary progressive multiple sclerosis","volume":"4","author":"Beynon","year":"2022","journal-title":"BMJ Neurol Open"},{"key":"2025011602331786800_awae013-B143","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1212\/NXI.0000000000001139","article-title":"Slowly expanding lesions predict 9-year multiple sclerosis disease progression","volume":"9","author":"Preziosa","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B144","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B145","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1212\/WNL.0000000000200144","article-title":"Association of slowly expanding lesions on MRI with disability in people with secondary progressive multiple sclerosis","volume":"98","author":"Calvi","year":"2022","journal-title":"Neurology"},{"key":"2025011602331786800_awae013-B146","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/1352458520969105","article-title":"Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis","volume":"27","author":"Preziosa","year":"2021","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B147","first-page":"3","article-title":"Effects of evobrutinib, a Bruton\u2019s tyrosine kinase inhibitor, on slowly expanding lesions: An emerging imaging marker of chronic tissue loss in multiple sclerosis","volume":"27","author":"Arnold","year":"2021","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B148","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/13524585231162262","article-title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Elliott","year":"2023","journal-title":"Mult Scler"},{"key":"2025011602331786800_awae013-B149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-387718-5.00002-X","article-title":"Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands","volume":"101","author":"Owen","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"2025011602331786800_awae013-B150","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis","volume":"123","author":"Banati","year":"2000","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B151","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2967\/jnumed.113.131698","article-title":"In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11CPK11195","volume":"55","author":"Rissanen","year":"2014","journal-title":"J Nucl Med"},{"key":"2025011602331786800_awae013-B152","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.nbd.2014.01.018","article-title":"Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study","volume":"65","author":"Giannetti","year":"2014","journal-title":"Neurobiol Dis"},{"key":"2025011602331786800_awae013-B153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.msard.2017.04.008","article-title":"Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation","volume":"15","author":"Kaunzner","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"2025011602331786800_awae013-B154","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1212\/NXI.0000000000000443","article-title":"Microglial activation, white matter tract damage, and disability in MS","volume":"5","author":"Rissanen","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B155","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awaa275","article-title":"Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis","volume":"143","author":"Sucksdorff","year":"2020","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B156","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.114.141713","article-title":"Imaging microglial activation with TSPO PET: Lighting up neurologic diseases?","volume":"57","author":"Vivash","year":"2016","journal-title":"J Nucl Med"},{"key":"2025011602331786800_awae013-B157","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cpet.2015.09.002","article-title":"MR imaging\u2013 guided partial volume correction of PET data in PET\/MR imaging","volume":"11","author":"Erlandsson","year":"2016","journal-title":"PET Clin"},{"key":"2025011602331786800_awae013-B158","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2967\/jnumed.116.183020","article-title":"Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis","volume":"58","author":"Sucksdorff","year":"2017","journal-title":"J Nucl Med"},{"key":"2025011602331786800_awae013-B159","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00415-011-6337-x","article-title":"Decreased microglial activation in MS patients treated with glatiramer acetate","volume":"259","author":"Ratchford","year":"2012","journal-title":"J Neurol"},{"key":"2025011602331786800_awae013-B160","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1212\/NXI.0000000000000574","article-title":"Natalizumab treatment reduces microglial activation in the white matter of the MS brain","volume":"6","author":"Sucksdorff","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B161","doi-asserted-by":"crossref","first-page":"e0201289","DOI":"10.1371\/journal.pone.0201289","article-title":"Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"key":"2025011602331786800_awae013-B162","doi-asserted-by":"crossref","first-page":"fcab301","DOI":"10.1093\/braincomms\/fcab301","article-title":"Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET","volume":"4","author":"Nylund","year":"2022","journal-title":"Brain Commun"},{"key":"2025011602331786800_awae013-B163","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2967\/jnumed.119.231340","article-title":"Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of worsening disability in multiple sclerosis","volume":"61","author":"Bodini","year":"2020","journal-title":"J Nucl Med"},{"key":"2025011602331786800_awae013-B164","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.26657","article-title":"Positron emission tomography with [18 F]-DPA714 unveils a smoldering component in most multiple sclerosis lesions which drives disease progression","volume":"94","author":"Hamzaoui","year":"2023","journal-title":"Ann Neurol"},{"key":"2025011602331786800_awae013-B165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","article-title":"Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain","volume":"35","author":"Cosenza-Nashat","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2025011602331786800_awae013-B166","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/brain\/awz287","article-title":"A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis","volume":"142","author":"Nutma","year":"2019","journal-title":"Brain"},{"key":"2025011602331786800_awae013-B167","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/glia.24052","article-title":"Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain","volume":"69","author":"Nutma","year":"2021","journal-title":"Glia"},{"key":"2025011602331786800_awae013-B168","doi-asserted-by":"crossref","first-page":"e200133","DOI":"10.1212\/NXI.0000000000200133","article-title":"TSPO-Detectable chronic active lesions predict disease progression in multiple sclerosis","volume":"10","author":"Polvinen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B169","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00259-008-0908-9","article-title":"Nuclear imaging of neuroinflammation: A comprehensive review of [11C]PK11195 challengers","volume":"35","author":"Chauveau","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025011602331786800_awae013-B170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12974-018-1352-9","article-title":"In vivo assessment of neuroinflammation in progressive multiple sclerosis: A proof of concept study with [18F]DPA714 PET","volume":"15","author":"Hagens","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2025011602331786800_awae013-B171","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2967\/jnumed.109.062265","article-title":"Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans","volume":"50","author":"Endres","year":"2009","journal-title":"J Nucl Med"},{"key":"2025011602331786800_awae013-B172","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-015-3043-4","article-title":"(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: Test-retest reproducibility and focal visualization of active white matter areas","volume":"42","author":"Park","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025011602331786800_awae013-B173","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1097\/RLU.0000000000002179","article-title":"18F-PBR06 versus 11C-PBR28 PET for assessing white matter translocator protein binding in multiple sclerosis","volume":"43","author":"Singhal","year":"2018","journal-title":"Clin Nucl Med"},{"key":"2025011602331786800_awae013-B174","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00259-018-3974-7","article-title":"TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis","volume":"45","author":"Unterrainer","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025011602331786800_awae013-B175","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1042\/BST20150058","article-title":"The methodology of TSPO imaging with positron emission tomography","volume":"43","author":"Turkheimer","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"2025011602331786800_awae013-B176","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00259-021-05248-9","article-title":"Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain","volume":"49","author":"Wimberley","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025011602331786800_awae013-B177","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00259-019-04403-7","article-title":"Effects of age, BMI and sex on the glial cell marker TSPO \u2014 A multicentre [11C]PBR28 HRRT PET study","volume":"46","author":"Tuisku","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025011602331786800_awae013-B178","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","article-title":"Safety and efficacy of tolebrutinib, an oral brainpenetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, doubleblind, placebo-controlled trial","volume":"20","author":"Reich","year":"2021","journal-title":"Lancet Neurol"},{"key":"2025011602331786800_awae013-B179","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1212\/NXI.0000000000001138","article-title":"Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions","volume":"9","author":"Zinger","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025011602331786800_awae013-B180"},{"key":"2025011602331786800_awae013-B181"},{"key":"2025011602331786800_awae013-B182"},{"key":"2025011602331786800_awae013-B183","author":"Queen Mary University of London"},{"key":"2025011602331786800_awae013-B184","author":"Zivadinov"},{"key":"2025011602331786800_awae013-B185","author":"National Institutes of Health Clinical Center"},{"key":"2025011602331786800_awae013-B186","author":"National Institutes of Health Clinical Center"},{"key":"2025011602331786800_awae013-B187","author":"National Institutes of Health Clinical Center"},{"key":"2025011602331786800_awae013-B188","author":"Turku University Hospital"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae013\/58583257\/awae013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/9\/2913\/59004128\/awae013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/9\/2913\/59004128\/awae013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:34:52Z","timestamp":1736994892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/9\/2913\/7558434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":188,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,1,16]]},"published-print":{"date-parts":[[2024,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae013","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,1,16]]}}}